Can a drug calm the bone marrow storm in myelofibrosis?
Disease control
Recruiting now
This study tests a drug called canakinumab in people with myelofibrosis, a serious bone marrow disorder. The goal is to see if it can improve symptoms, anemia, or reduce an enlarged spleen. About 14 adults will receive injections every 3 weeks for 8 cycles, and researchers will c…
Phase: PHASE2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Apr 29, 2026 07:14 UTC